79
Growth Score in past quarter
pts
Heat Score 79 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
190068
kaiko.ai develops AI assistant for oncology powered by multimodal models trained specifically on cancer data to support clinical decisions.
- Robert Berke: CTO & Co-founder
- Thomas Hufener: CEO & Co-founder
About the Company
Founded in 2021 and backed by the Hartwig Foundation, kaiko.ai is a deep-tech healthcare AI company that brings advanced AI to clinical oncology.
Cancer patient data is complex, large-scale and fragmented across clinical notes, pathology, imaging, and genomics. At kaiko.ai, we build specialized AI models (MLLMs) specifically trained on cancer
data to make sense of this information and bring this understanding to clinicians via our AI assistant kaiko.w.
Our team develops these models in-house through partnerships with leading cancer institutes, validating solutions in live hospital environments across Switzerland and the Netherlands.